1-3 of 3
Jennifer Gyamfi
Close
Sort by
Journal Articles

Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma

Nakhle S. Saba, Delong Liu, Sarah E. M. Herman, Chingiz Underbayev, Xin Tian, David Behrend, Marc A. Weniger, Martin Skarzynski, Jennifer Gyamfi, Lorena Fontan, Ari Melnick, Cliona Grant, Mark Roschewski, Alba Navarro, Sílvia Beà, Stefania Pittaluga, Kieron Dunleavy, Wyndham H. Wilson, Adrian Wiestner
Journal: Blood
Blood (2016) 128 (1): 82–92.
https://doi.org/10.1182/blood-2015-11-681460
Published: 2016
Includes: Supplemental data
Journal Articles

Effective Inhibition Of Tumor Microenvironment Interactions In CLL Patients Treated With The BTK Inhibitor Ibrutinib Results In Sustained Inhibition Of Tumor Proliferation and Survival Pathways

Sarah E. M. Herman, PhD, Rashida Z Mustafa, BS, Sabrina E. Martyr, MD, Jennifer Gyamfi, MS, Janet Valdez, PA, Susan Soto, RN, Mohammed Farooqui, DO, Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 118.
https://doi.org/10.1182/blood.V122.21.118.118
Published: 2013
Journal Articles

Ibrutinib Inhibits B-Cell Adhesion and Causes An Efflux Of Chronic Lymphocytic Leukemia Cells From The Tissue Microenvironment Into The Blood Leading To a Transient Treatment-Induced Lymphocytosis

Rashida Z Mustafa, BS, Sarah E. M. Herman, PhD, Jade Jones, Jennifer Gyamfi, MS, Mohammed Farooqui, DO, Adrian Wiestner, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 674.
https://doi.org/10.1182/blood.V122.21.674.674
Published: 2013